Self-pressurized Air-Q With Blocker and Air-Q Blocker in Low Risk Female Patients Undergoing Ambulatory Surgery
|
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. |
| ClinicalTrials.gov Identifier: NCT03816969 |
|
Recruitment Status :
Completed
First Posted : January 25, 2019
Last Update Posted : July 26, 2021
|
- Study Details
- Tabular View
- No Results Posted
- Disclaimer
- How to Read a Study Record
| Condition or disease | Intervention/treatment | Phase |
|---|---|---|
| Ambulatory Surgery | Device: Self-pressurized air-Q with blocker Device: Air-Q ILA blocker | Not Applicable |
| Study Type : | Interventional (Clinical Trial) |
| Actual Enrollment : | 40 participants |
| Allocation: | Randomized |
| Intervention Model: | Parallel Assignment |
| Intervention Model Description: | It has a drain tube through which a suction tube is passed like the Air-QILA blocker, and Instead of the pilot balloon and inflating cuff, the air-Q SP with blocker incorporates a self-regulating periglottic cuff at the end of this tube, a communication orifice at the junction of the peri-glottic cuff and the airway tube. This communication between two spaces enables the cuff to dynamically regulate intra-cuff pressure depending on airway pressure. This distinguishing feature of the air-Q SP may result in reduced risk for airway morbidities related to cuff hyperinflation. |
| Masking: | Double (Participant, Investigator) |
| Masking Description: | An online randomization program (http://www.randomizer.org) will be used to generate random list and to allocate patients into the study groups. Random allocation numbers will be concealed in opaque closed envelops. The patient and investigator assessing study outcomes will all be blinded to the study groups allocation. |
| Primary Purpose: | Supportive Care |
| Official Title: | A Prospective Randomized Comparative Study Between the Self-pressurized Air-Q With Blocker and Air-Q Blocker in Low Risk Female Patients Undergoing Ambulatory Surgery |
| Actual Study Start Date : | January 5, 2018 |
| Actual Primary Completion Date : | January 10, 2019 |
| Actual Study Completion Date : | January 18, 2019 |
| Arm | Intervention/treatment |
|---|---|
|
Active Comparator: Self-pressurized air-Q with blocker
Self-pressurized air-Q with blocker has a greater seal pressure compared to Air-Q blocker, easier and faster in insertion and has less morbidity and complications while and after insertion
|
Device: Self-pressurized air-Q with blocker
It has a drain tube through which a suction tube is passed like the Air-QILA blocker, and Instead of the pilot balloon and inflating cuff, the air-Q SP with blocker incorporates a self-regulating periglottic cuff at the end of this tube , a communication orifice at the junction of the peri-glottic cuff and the airway tube. This communication between two spaces enables the cuff to dynamically regulate intra-cuff pressure depending on airway pressure. This distinguishing feature of the air-Q SP may result in reduced risk for airway morbidities related to cuff hyperinflation |
|
Active Comparator: Air-Q ILA blocker
It has a drain tube through which a suction tube is passed
|
Device: Air-Q ILA blocker
A good seal will provide good ventilation, will guarantee the desired depth of anesthesia at lower gas flows and with lesser leaks to the esophagus, it will not cause rise in intragastric pressure thus preventing regurgitation However, When the cuff pressure is more than the mucosal perfusion pressure, it is likely to either cause postoperative pharyngo-laryngeal symptoms (sore throat, dysphagia, dysphonia) or cause local mucosal trauma and nerve injuries |
- Oropharyngeal leak pressure [ Time Frame: 10 Minutes after initial assessment ]The Oropharyngeal leak pressure after insertion and fixation of the device
- Insertion time [ Time Frame: 10 Minutes ]time of insertion
- Complications associated [ Time Frame: 24 hours ]Hypoxemia (SpO2 <90%), intra and postoperative
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.
| Ages Eligible for Study: | 18 Years to 50 Years (Adult) |
| Sexes Eligible for Study: | Female |
| Accepts Healthy Volunteers: | Yes |
Inclusion Criteria:
- Female patients between the age group of 18 and 50 years.
- Patients of American Society of Anaesthesiologists (ASA) class I and II.
- Patients with Ganzouri airway score less than 4.
Exclusion Criteria:
- ASA III - V patients.
- Airway score ≥ 4 according to El-Ganzouri Airway Scoring System.
- Patients with any oropharyngeal pathology.
- Patients known to have risk of gastric aspiration, gastro-esophageal reflux disease, hiatus hernia or previous upper gastrointestinal tract surgery
To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT03816969
| Egypt | |
| Ahmed Abdalla Mohamed | |
| Cairo, Egypt, 11451 | |
| Principal Investigator: | Ahmed Abdalla Mohamed, M.D | Cairo University |
| Responsible Party: | Ahmed Abdalla, Professor of Anesthesia &I.C.U and Pain Clinic, Cairo University, Cairo University |
| ClinicalTrials.gov Identifier: | NCT03816969 |
| Other Study ID Numbers: |
N 1- 2018/Ms |
| First Posted: | January 25, 2019 Key Record Dates |
| Last Update Posted: | July 26, 2021 |
| Last Verified: | July 2021 |
| Individual Participant Data (IPD) Sharing Statement: | |
| Plan to Share IPD: | Undecided |
| Plan Description: | Till Press |
| Studies a U.S. FDA-regulated Drug Product: | No |
| Studies a U.S. FDA-regulated Device Product: | No |
|
Self-pressurized Air Q |

